Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes

Toxicology in Vitro

Volumn 27, Issue 4, 2013, Pages 1267-1276

  Schmidt, Jan ^a   Kotnik, Petra ^b   Trontelj, Jurij ^a   Knez, Željko ^b   Mašič, Lucija Peterlin ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Bisphenols; Human liver microsomes; LC MS MS; Reactive metabolites

Indexed keywords

3,30 DIMETHYLBISPHENOL A; 4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL AF; BISPHENOL F; BISPHENOL Z; CYTOCHROME P450; GLUTATHIONE; INDUSTRIAL CHEMICAL; ISOENZYME; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; ELECTROPHILICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME METABOLISM; METABOLITE; QUADRUPOLE MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

BENZHYDRYL COMPOUNDS; BIOTRANSFORMATION; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; ENDOCRINE DISRUPTORS; ESTROGENS; GLUTATHIONE; HUMANS; ISOENZYMES; MICROSOMES, LIVER; NADP; PHENOLS; RECOMBINANT PROTEINS; TANDEM MASS SPECTROMETRY;

MUS;

EID: 84875597848     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.02.016     Document Type: Article

References (34)

1. Bolton J.L., Thatcher G.R. Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol. 2008, 21:93-101.
2. Bolton J.L., Acay N.M., Vukomanovic V. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol. 1994, 7:443-450.
3. Cabaret O., Puel O., Botterel F., Pean M., Khoufache K., Costa J.M., Delaforge M., Bretagne S. Metabolic detoxication pathways for sterigmatocystin in primary tracheal epithelial cells. Chem. Res. Toxicol. 2010, 23:1673-1681.
4. Cabaton N., Zalko D., Rathahao E., Canlet C., Delous G., Chagnon M.C., Cravedi J.P., Perdu E. Biotransformation of bisphenol F by human and rat liver subcellular fractions. Toxicol. In Vitro. 2008, 22:1697-1704.
5. Cabaton N., Dumont C., Severin I., Perdu E., Zalko D., Cherkaoui-Malki M., Chagnon M.C. Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line. Toxicology 2009, 255:15-24.
6. Commission Directive 2011/8/EU of 28 January 2011 amending Directive 2002/72/EC as regards the restriction of use of Bisphenol A in plastic infant feeding bottles Text with EEA relevance.
7. Danzl E., Sei K., Soda S., Ike M., Fujita M. Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater. Int. J. Environ. Res. Public Health. 2009, 4:1472-1484.
8. Dieckhaus C.M., Fernández-Metzler C.L., King R., Krolikowski P.H., Baillie T.A. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 2005, 18:630-638.
9. Driscoll J.P., Kornecki K., Wolkowski J.P., Chupak L., Kalgutkar A.S., O'Donnell J.P. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate. Chem. Res. Toxicol. 2007, 20:1488-1497.
10. Edmonds J.S., Nomachi M., Terasaki M., Morita M., Skelton B.W., White A.H. The reaction of bisphenol A 3,4-quinone with DNA. Biochem. Biophys. Res. Commun. 2004, 319:556-561.
11. Evans D.C., Watt A.P., Nicoll-Griffith D.A., Baillie T.A. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 2004, 17:3-16.
12. Fang H., Tong W., Shi L.M., Blair R., Perkins R., Branham W., Hass B.S., Xie Q., Dial S.L., Moland C.L., Sheehan D.M. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 2001, 3:280-294.
13. Feldman D., Tokes L., Stathis P.A., Miller S.C., Kurz W., Harvey D. Identification of 17b-estradiol as the estrogenic substance in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1984, 81:4722-4726.
14. Ginsberg G., Rice D.C. Does rapid metabolism ensure negligible risk from bisphenol A?. Environ. Health Perspect. 2009, 117:1639-1643.
15. Hoag M.K.P., Trevor A.J., Kalir A. Phencyclidine iminium ion: NADPH-dependent metabolism, covalent binding to macromolecules, and inactivation of cytochrome(s) P-450. Drug Metab. Dispos. 1987, 15:485-490.
16. Jaeg J.P., Perdu E., Dolo L., Debrauwer L., Cravedi J.P., Zalko D. Characterization of new bisphenol A metabolites produced by CD1 mice liver microsomes and S9 fractions. J. Agric. Food Chem. 2004, 52:4935-4942.
17. Kalgutkar A.S., Gardner I., Obach R.S., Shaffer C.L., Callegari E., Henne K.R., Mutlib A.E., Dalvie D.K., Lee J.S., Nakai Y., O'Donnell J.P., Boer J., Harriman S.P. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 2005, 6:161-225.
18. Kovacic P. How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med. Hypotheses. 2010, 75:1-4.
19. Krol E.S. Metabolic detoxication pathways for sterigmatocystin in primary tracheal epithelial cells: structural identification of glutathione adducts. Chem. Res. Toxicol. 2011, 24:1339-1340.
20. Ma S., Zhu M. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites. Chem. Biol. Interact. 2009, 179:25-37.
21. Markey C.M., Michaelson C.L., Veson E.C., Sonnenschein C., Soto A.M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 2001, 109:55-60.
22. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors α and β. Chem. Res. Toxicol. 2001, 14:149-157.
23. Nakagawa Y., Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch. Toxicol. 2000, 74:99-105.
24. Nakamura S., Tezuka Y., Ushiyama A., Kawashima C., Kitagawara Y., Takahashi K., Ohta S., Mashino T. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol. Lett. 2011, 203:92-95.
25. NTP, 2008. Chemical information profile for bisphenol AF [CAS No. 1478-61-1], Supporting Nomination for Toxicological Evaluation by the National Toxicology Program, >. (accessed 30.03.11). http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/BisphenolAF_093008_508.pdf.
26. Niwa T., Fujimoto M., Kishimoto K., Yabusaki Y., Ishibashi F., Katagiri M. Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17. Biol. Pharm. Bull. 2001, 24:1064-1067.
27. Peterson L.A., Cummings M.E., Vu C.C., Matter B.A. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab. Dispos. 2005, 33:1453-1458.
28. Pritchett J.J., Kuester R.K., Sipes I.G. Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab. Dispos. 2002, 30:1180-1185.
29. Qiu S.X., Yang R.Z., Gross M.L. Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates. Chem. Res. Toxicol. 2004, 17:1038-1046.
30. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 1:75-95.
31. Yoshihara S., Makishima M., Suzuki N., Ohta S. Metabolic activation of bisphenol A by rat liver S9 fraction. Toxicol. Sci. 2001, 62:221-227.
32. Yoshihara S., Mizutare T., Makishima M., Suzuki N., Fujimoto N., Igarashi K., Ohta S. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 2004, 78:50-59.
33. Zalko D., Soto A.M., Dolo L., Dorio C., Rathahao E., Debrauwer L., Faure R., Cravedi J.P. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ. Health Perspect. 2003, 111:309-319.
34. Zhao Z., Leung L.Y., Trevor A., Castagnoli N. C-Formylation in the presence of rat brain mitochondria of the 2,3,4,5-tetrahydropyridinium metabolite derived from the psychotomimetic drug phencyclidine. Chem. Res. Toxicol. 1991, 4:426-429.